ClinicalTrials.gg
Not yet recruitingNCT07676019Updated Jun 30, 2026

Psychometric Properties of the Turkish Version of the Staffordshire Adolescent Idiopathic Scoliosis Questionnaire

An observational study in Scoliosis and Quality of Life, sponsored by Acibadem University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 10 Years to 19 Years. Per ClinicalTrials.gov, last updated 2026-06-30.

Sponsored by Acibadem University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
10 Years to 19 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 132 studies in Scoliosis with a site in Turkey — 32 open to participants now, 35 under way, none of them phase 3. Scoliosis · Turkey.

Planned enrollment
14th of 54
100 · median 60
Started
2026
with 15 others
Observational
54 of 132
17 open now
Primary completion
2027-01
later than 28 of 34 live
Registered
122nd of 132
by date

Among the 132 studies in Scoliosis with a site in Turkey, this one is the 14th largest by planned enrollment of the 54 observational ones that give a count, is one of 16 that started in 2026, is one of 54 observational ones, reaches primary completion later than 28 of the 34 other live ones, and was the 122nd registered.

Scoliosis

660 studies on the registry are indexed under Scoliosis; 185 are open to participants now.

Browse Scoliosis studies →

Open to participants now

32 of the 132 studies in Scoliosis with a site in Turkey are open now. Recruiting first, the newest first:

26 more — sign in →

All 32 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 117 Scoliosis studies recruiting now, 23 (20%) set no upper age limit and 88 (75%) stop at 75 or younger; 98 take children under 18; 14 take healthy volunteers.

This study: 10 Years to 19 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 132 studies in Scoliosis with a site in Turkey, or all of them as a file.
02

Study summary

Patient-Reported Outcome Measures (PROMs) have gained increasing importance in scoliosis research in recent years. Although widely used instruments such as the Scoliosis Research Society-22 (SRS-22) include domains related to body image, their primary purpose is to assess overall health-related quality of life and functional outcomes. In contrast, the Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis (SQAIS) was specifically developed to provide a more detailed and patient-centered evaluation of body image and perceived deformity in individuals with adolescent idiopathic scoliosis (AIS). However, a Turkish version of the questionnaire with established validity and reliability is not currently available.

Therefore, the aim of the planned master's thesis is to conduct the cultural adaptation of the Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis into Turkish and to evaluate its psychometric properties in adolescents with AIS. The study will involve a systematic process of linguistic translation and cross-cultural adaptation. Subsequently, the validity and reliability of the Turkish version will be assessed through analyses of internal consistency, test-retest reliability, construct validity, and criterion validity.

The findings of this study are expected to provide a valid and reliable instrument for assessing body image and deformity perception among Turkish adolescents with idiopathic scoliosis, thereby contributing an important patient-centered outcome measure to both clinical practice and research.

03

Conditions studied

  • Scoliosis
  • Quality of Life

Browse trials for

04

Who can participate

Ages eligible
10 Years to 19 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of adolescents aged 10-19 years with a diagnosis of Adolescent Idiopathic Scoliosis (AIS) who are being followed in orthopedic and rehabilitation clinics

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 10 and 19 years.
  • Diagnosed with Adolescent Idiopathic Scoliosis (AIS) by an orthopedic surgeon or spine specialist.
  • Able to read and understand Turkish.

Exclusion criteria

Exclusion Criteria

  • Diagnosis of congenital, neuromuscular, or syndromic scoliosis.
  • History of severe neurological, psychiatric, or cognitive disorders.
  • Presence of communication impairments that may interfere with understanding or completing the questionnaires.
  • History of major trauma or spinal surgery within the previous 6 months.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No

Groups and cohorts

  • Scoliosis

    Other: Turkish Version of the Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis (SQAIS)

Interventions

  • OtherTurkish Version of the Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis (SQAIS)

    Administration of the Turkish version of the Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis to evaluate body image and perceived deformity in adolescents with idiopathic scoliosis.

06

What researchers measure

Primary outcomes

  1. Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis

    The Turkish version of the Staffordshire Questionnaire for Adolescent Idiopathic Scoliosis (SQAIS) will be administered to assess body image and perceived spinal deformity in adolescents with idiopathic scoliosis. The questionnaire consists of items evaluating patients' perceptions of their appearance and scoliosis-related concerns. Item scores are summed to obtain a total score. Higher scores indicate greater body image disturbance, poorer perception of appearance, and a greater perceived impact of scoliosis-related deformity. Test-retest reliability will be evaluated by re-administering the questionnaire 15-21 days after the initial assessment.

    Time frame: Baseline (Day 1) and 15-21 days after baseline.

Secondary outcomes

  1. Scoliosis Research Society-22 Questionnaire

    The Scoliosis Research Society-22 (SRS-22) questionnaire will be used to assess health-related quality of life in adolescents with idiopathic scoliosis. The questionnaire consists of 22 items distributed across five domains: Function/Activity, Pain, Self-Image/Appearance, Mental Health, and Satisfaction with Management. Items are scored on a 5-point Likert scale. Domain scores and a total score are calculated, with higher scores indicating better health-related quality of life, better function, less pain, more positive self-image, and better mental health.

    Time frame: Baseline (Day 1)

  2. Spinal Appearance Questionnaire

    The Spinal Appearance Questionnaire (SAQ) will be used to assess patients' perceptions of spinal deformity and body appearance related to scoliosis. The questionnaire consists of appearance-related items evaluating perceptions of trunk shape, posture, asymmetry, and overall spinal appearance. Scores are calculated for individual domains and as a total score. Higher scores indicate a more negative perception of spinal appearance and greater perceived deformity.

    Time frame: Baseline (Day 1)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Jan 2027, 6 months later.

Of 94 non-industry observational studies under Scoliosis, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 99. This study's planned 6 months is below that.

Counting every sponsor, half of 106 studies reached it within 36 months; a quarter within 9 and three quarters within 92.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 24, 2026
First posted
Jun 30, 2026
StartEst.
Jul 2, 2026
Primary completionEst.
Jan 2, 2027
CompletionEst.
Mar 2, 2027
Last update
Jun 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07676019
Responsible party
Nuray Alaca (Assoc. Prof. Nuray Alaca, Acibadem University) — Principal investigator
First posted
Jun 30, 2026
Start date
Jul 2, 2026 (estimated)
Primary completion
Jan 2, 2027 (estimated)
Completion
Mar 2, 2027 (estimated)
Last update
Jun 30, 2026

Study contacts

Nuray ALACA
Contact
nuray.alaca@acibadem.edu.tr
05324251290

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion